Seth Goldberg, MD
Nephrology · Saint Louis, MONPI 1174640114
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $129 of the $190 with a category attached, or 67.8%. W. L. Gore & Associates, Inc. accounts for 67.8% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for nephrology clinicians in MO, where the typical reported total is $723.
Across 2 payments — averaging $95.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$129
- Otsuka America Pharmaceutical, Inc.$61
Across 12 payments — averaging $9182.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kadmon Corporation LLC$58K
- AbbVie$31K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$20K
- Sanofi US Services Inc.$2K
What the payments were for
- Food & beverage$12968%
- Education$6132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 1 | $129 |
| Otsuka America Pharmaceutical, Inc. | 1 | $61 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$190 in reported general payments places this provider in the 20th percentile of 253 nephrology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Everolimus | 26 | $231,835 |
| Potassium Citrate ErPotassium Citrate | 76 | $9,490 |
| JardianceEmpagliflozin | 13 | $7,735 |
| Calcitriol | 75 | $1,413 |
| Potassium Chloride | 14 | $520 |
| Chlorthalidone | 33 | $398 |
| Metoprolol Succinate | 22 | $218 |
| Losartan Potassium | 16 | $177 |
| Lisinopril | 25 | $146 |
| Furosemide | 16 | $101 |
| Amlodipine Besylate | 29 | $100 |
| Hydrochlorothiazide | 20 | $98 |
| Allopurinol | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Saint Louis
- Marcos RothsteinSaint Louis$350K
- Anuja JavaSaint Louis$240K
- Daniel CoyneSaint Louis$163K
- Tarek AlhamadSaint Louis$155K
- Tingting LiSaint Louis$130K
- Krista LentineSaint Louis$86K
- Rowena Delos SantosSaint Louis$30K
- Kabeya MwintshiSaint Louis$25K
- Naoka MurakamiSaint Louis$24K
- Benjamin HumphreysSaint Louis$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.